echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The price of Lianhua Qingwen has increased by 6 times! Industry insiders: There is no need to stock up on medicines, hospitals have sufficient reserves

    The price of Lianhua Qingwen has increased by 6 times! Industry insiders: There is no need to stock up on medicines, hospitals have sufficient reserves

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Is it true that a box of cold medicine is hard to come by?

    On December 6, the Health Bureau visited several pharmacies in Beijing, where all kinds of cold medicines and vitamin products were placed in the most conspicuous position on the counter, and the only non-cold medicine that could be squeezed in the C position was sildenafil
    citrate.

    A number of pharmacy staff said that Lianhua Qingwen and ibuprofen products have been sold out, and "we can't say when we can replenish the goods"
    .
    One staff member suggested picking the products stacked on the counter with whatever you wanted, "the effect is similar.
    "

    Lianhua Qingwen and ibuprofen have been sold short,

    In December, as various places have successively adjusted their new crown epidemic prevention policies, the sentiment of "hoarding medicine" is also quietly spreading, what is the real situation?

    One of the first cities to adjust was Guangzhou
    .
    According to Ding Li, deputy director of the Guangzhou Market Supervision Bureau, on December 1, the sales records of cold and fever drugs in pharmacies in Guangzhou reached 100,000 in one day, 2.
    5 times that of weekdays, and "the public's demand for drugs has soared"
    .

    The sales record of cold and fever drugs reached 100,000 in one day, which was 2.
    5 times that of weekdays.

    On December 6, the Health Bureau saw on the online drug purchase platform of some pharmacies that the price of a box of 0.
    35g and 24 capsules of Lianhua Qingwen capsules was close to 60 yuan, but in the past, this price was about 10 yuan, and now the price has increased by 6 times, but it is still "out of stock"
    .

    The price of a box of 0.
    35g and 24 capsules of Lianhua Qingwen capsules has been close to 60 yuan, a six-fold increase in price, but it is still "out of stock
    ".

    Some media said that Lianhua Qingwen even "increased prices three times a day"
    on some e-commerce platforms.

    A number of medical practitioners told the Health Bureau that there is no need for individual residents to stock up on a large number of medicines, and the specific use of drugs should also be carried out under the guidance of doctors, but it is necessary for the people to suddenly accept "Omicron is not so terrible" matter, I am afraid it will take time
    .

    It is necessary to make the common people suddenly accept "Omicron is not so terrible" matter, I am afraid it will take time
    .

    Medical institutions are well stocked, and there is no need for individuals to stock up on medicines

    Medical institutions are well stocked, and there is no need for individuals to stock up on medicines

    Recently, a "new crown medicine order chart" has been widely circulated on the Internet
    .

    According to the sequence chart, according to the development of the disease, patients need to choose different drugs in the early, middle and late stages and prevention stages, including Lianhua Qingwen capsules, ibuprofen sustained-release capsules, Pudi blue anti-inflammatory tablets, etc.
    , which are also popular products
    that are currently out of stock in many places.

    Lianhua Qingwen capsules, ibuprofen sustained-release capsules, Pudi blue anti-inflammatory tablets, etc.
    are among them, which are also popular products
    that are currently out of stock in many places.

    On December 5, a Beijing resident surnamed Li told the Health Bureau that after seeing the picture, she immediately "copied her homework and bought it one by one", "Now that the control is not so strict, I feel that personal protection is very important
    .
    " ”

    Since December, with the announcement of the optimization and adjustment of epidemic prevention and control measures in many places across the country, "hoarding medicine" has become a knee-jerk reaction
    of residents to respond to policy changes.
    On December 5, an institutional survey minutes disclosed by China Resources Sanjiu said that after the epidemic was relaxed, consumer behavior "did change", the number of one-time purchases increased, and the unit price of customers "increased significantly compared with before"
    .

    Consumer behavior "has indeed changed", with an increase in one-time purchases and a "significantly higher unit price than before"
    .

    This "hoarding" mood gradually develops
    in an irrational direction.
    According to data released by the Guangdong Provincial Food and Drug Administration, at present, wholesale enterprises in the province "distribute 3.
    6 million boxes of cold medicines per day to 55,000 retail pharmacies in the province", but the short-term explosive growth of such cold products is not sustainable, and "180% of the growth in sales is mainly based on the purchase of spare products, not the real demand"
    .

    The short-term explosive growth of cold products is not sustainable, "180% of the growth is mainly based on buying spares, not real demand"
    .

    On December 5, a medical worker in Shandong told the Health Bureau that there is no need for individual residents to stock up on a large number of drugs to prevent the new crown, and that everyone's specific symptoms may be different, and symptomatic medication
    should be used under the guidance of a doctor.

    He introduced that on the evening of December 4, at the same time that Shandong Province issued a notice relaxing epidemic control at the provincial level, his district has asked all types of medical institutions at all levels to urgently reserve sufficient amounts of new crown treatment drugs, and the procurement list includes both Pfizer's nematevir/ritonavir tablets and other new crown treatment drugs with clear effects, as well as common drugs
    such as Lianhua Qingwen capsules and Xuanlung sepsis granules.

    The procurement list includes both Pfizer's nematevir/ritonavir tablets and other new crown treatment drugs with clear effects, as well as common drugs
    such as Lianhua Qingwen capsules and Xuanlung sepsis granules.

    "There is no need to stock up on medicine, the hospital has sufficient
    reserves.
    " The person emphasized
    .

    On December 2, Ding Li, deputy director of the Guangzhou Market Supervision Bureau, also said at the press conference that it is good that residents' awareness of self-prevention and protection of the epidemic has increased, but there is no need to blindly stock up on a large number of medicines
    .

    Ding Li, Deputy Director of Guangzhou Market Supervision Bureau

    On December 3, the Guangdong Provincial Food and Drug Administration posted on its official WeChat public account that "the relevant drug hoarding guidelines are not scientific on the Internet", and that it is possible to buy a small number of short-term, daily urgently needed spare drugs, but a large number of irrational drug hoarding behaviors in the long term are unnecessary
    .
    Drugs have a shelf life, and storage also has certain conditions, too many drugs long-term storage is easy to cause waste
    .

    Drugs have a shelf life, and storage also has certain conditions, too many drugs long-term storage is easy to cause waste
    .

    Some cold medicines have taken the opportunity to raise prices and have been named by regulatory authorities

    Some cold medicines have taken the opportunity to raise prices and have been named by regulatory authorities

    At present, irrational people may not only hoard medicine, but also cold medicine sellers
    .

    On December 6, in the online drug purchase platform of some pharmacies, a box of 0.
    35g and 24 capsules of Lianhua Qingwen capsules was sold for nearly 60 yuan, and it was still out of stock, but in the past, the price of products with the same specifications was only more than 10 yuan
    .

    A box of 0.
    35g and 24 capsules of Lianhua Qingwen capsules is priced at nearly 60 yuan.

    According to Red Star Capital Bureau, on December 6, the unit price of some Lianhua Qingwen capsules with a specification of 0.
    35g and 48 capsules on an e-commerce platform has reached 102 yuan, an increase of 240%.

    The unit price of .
    35g, 48 capsules a box of Lianhua Qingwen capsules has reached 102 yuan, an increase of 240%.

    In response to the recent "price increase" of cold products, the Hangzhou Municipal Administration for Market Supervision posted on its WeChat public account on December 5 that after the adjustment of epidemic control measures in the city, it has noticed that Lianhua Qingwen and other popular commodities purchased by consumers, and prices have also increased
    to a certain extent.
    In this regard, Hangzhou requires merchants to "not take the opportunity of epidemic prevention and control to significantly increase the sales price of medical drugs and supplies", and violators may be fined
    up to 5 million yuan.

    Hangzhou requires merchants to "not take advantage of the epidemic prevention and control to significantly increase the sales price of medical drugs and supplies", and violators may be fined
    up to 5 million yuan.

    In addition, the Hangzhou Market Supervision Bureau stressed that the market supervision department will seriously deal with illegal acts that are not rectified after the reminder, and publicly expose typical cases
    with egregious circumstances.

    According to Ding Li, Guangzhou has also recently focused on the work of "ensuring supply and stabilizing prices" of drugs, and the Market Supervision Bureau has carried out full-coverage supervision and inspection of more than 7,200 pharmacies in the city, and will conduct dynamic real-time monitoring of the prices of epidemic prevention drugs and related products, and promptly investigate and deal with price violations
    .

    The Health Bureau has noticed that some platforms have launched a parity version of "futures" Lianhua Qingwei
    .
    On the self-operated platform of Jingdong Pharmacy, a box of 0.
    35g and 24 capsules of Lianhua Qingwen is priced at 14.
    8 yuan
    .
    However, the product will not be available
    until after December 15.

    The parity version of "futures" is even flowered and cleared
    .
    The product will not be available
    until after December 15.

    As market demand grows, most manufacturers of cold-related drugs are stepping up stocking and ensuring supply, after the Health Insight Bureau investigated Yiling Pharmaceutical's urgent recruitment of a large number of temporary workers in Beijing to produce Lianhua Qingwei
    .
    On December 6, in response to investors' questions, Jinshi Yapharm said that the sales of crack and small crack products are recovering, "the steady growth of the cold category can be expected", the company's production capacity and stock are sufficient to meet market demand
    .

    Most manufacturers of cold-related drugs are stepping up stockpiling and securing supplies, after the Health Intelligence Bureau investigated Yiling Pharmaceutical's urgent recruitment of a large number of temporary workers in Beijing to produce Lianhua Qingwen
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.